Friday, May 29, 2020   05:48 EET
print version


The role of E6/E7 HPV16 oncogenes in chromatin remodelling through components of NuRD complex (MBD2, MBD3)

Project Code: PN-II-RU-TE-2014-4-2502



1.    Vogt M, Munding J, Grüner M, Liffers ST, Verdoodt B, Hauk J, Steinstraesser L, Tannapfel A, Hermeking H. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcoma. Virchows Archiv March 2011, 458 (3):313-322

2.    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin., 61, 69 90 (2011)

3.    I. Apostol, A. Baban, F. Nicula, O. Suteu, D. Coza, C. Amati, P. Baili, Cervical cancer assessment in Romania under EUROCHIP-2. Tumori., 96, 545-552 (2010).

4.    Nishimura A, Nakahara T, Ueno T, Sasaki K, Yoshida S et al, Requirement of E7 oncoprotein for viability of HeLa cells. Microbes Infect., 8, 984–993 (2006).

5.    Woodman CB, Collins SI, Young LS, The natural history of cervical HPV infection: unresolved issues, Nature reviews. Cancer., 7, 11-22 (2007).

6.    Zocchi L and Sassone-Corsi P 2010 Joining the dots: from chromatin remodeling to neuronal plasticity; Curr. Opin.Neurobiol. 20 432–440.

7.    McCabe MT, Davis JN and Day ML: Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 65: 3624-3632, 2005.

8.    Zhang Y, Yinghua L (2010). "The Expanding Mi-2/NuRD Complexes: A Schematic Glance". Proteomics Insights 3: 79–109. doi:10.4137/PRI.S6329.

9.    Lin Z, Bazzaro M, Wang M, Chan K C, Peng S and Roden R B 2009 Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment; Clin. Cancer Res. 15 570–577

10.    Denslow, SA; Wade, PA. 2007 "The human Mi-2/NuRD complex and gene regulation". Oncogene 26: 5433–8. doi:10.1038/sj.onc.1210611. PMID 17694084